BIOMAT Database Logo BIOMAT Database Logo

1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3',4'-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties. 2005

Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Dipartimento di Scienze Farmaceutiche, Università di Genova, Viale Benedetto XV, 3, I-16132 Genova, Italy. dbraccio@unige.it

A series of 11 new 9H-bis-[1,2,4]triazolo[4,3-a:3',4'-d] [1,5]benzodiazepine derivatives 8e-o was synthesized. Ten of these compounds (8e-m,o), along with four analogues (8a-d) (previously synthesized by us) were tested in vitro in order to evaluate their cytotoxic and anti-HIV-1 properties. In this connection other six original compounds, i.e., five 9-substituted compounds prepared starting from the 6,12-diphenylderivative 8c (compounds 10, 11, 12, 13a,b) and the bis-triazolone derivative 14, were synthesized and tested for the same purpose. While none of the 20 compounds tested exhibited any appreciable anti-HIV-1 activity, some of them exhibited interesting cytotoxic properties, the best results being shown by compounds 8c,d,k and 11 (CC(50) range=3-12 microM). Therefore, these four compounds were further evaluated for their antiproliferative activity against a panel of human tumor cell lines; actually, compounds 8d, 8k and 11 showed antiproliferative properties against either or both leukemia- and lymphoma-derived cell lines in the low micromolar range.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
New 1-(3-nitrophenyl)-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines: synthesis and computational study.
March 2015, Molecules (Basel, Switzerland),
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
January 1988, Journal of medicinal chemistry,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
3-Aryl-5-aminobiphenyl Substituted [1,2,4]triazolo[4,3-c]quinazolines: Synthesis and Photophysical Properties.
February 2023, Molecules (Basel, Switzerland),
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants.
March 2009, European journal of medicinal chemistry,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents.
January 2011, Acta poloniae pharmaceutica,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
6-(Substituted-amino)-4H-s-triazolo[4,3-a][1,4]benzodiazepines and 4-(substituted-amino)-6H-s-triazolo[4,3-a][1,4]benzodiazepines with potential antianxiety activity.
August 1980, Journal of medicinal chemistry,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Phosphorino(4,3-d)pyrimidines. 3. Synthesis, resolution, and properties of 4-substituted phosphorino(4,3-d)pyrimidines.
May 1973, The Journal of organic chemistry,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
January 2021, Bioorganic & medicinal chemistry,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
[1,5-Dioxo-4-aryl-2,4,5-tetrahydro-s-triazolo[4,3-a]-quinazolines and 1-ethoxycarbonylmethyl-4-aryl-s-triazolo[4,3-a]-quinazolones-(5). 3. Synthesis of compounds with an aminoguanidine structure].
January 1978, Die Pharmazie,
Mario Di Braccio, and Giancarlo Grossi, and Maurizio Ceruti, and Flavio Rocco, and Roberta Loddo, and Giuseppina Sanna, and Bernardetta Busonera, and Marta Murreddu, and Maria Elena Marongiu
Synthesis and pharmacological properties of new 3-ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines.
September 2002, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!